Reaction

Keratosis Follicular reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 78 reports · 1 co-occurring drugs

As of the last recalculation, Keratosis Follicular appears in 78 FAERS reports alongside 1 co-occurring drug terms. The strongest observed disproportionality signal is ENCORAFENIB (PRR 143.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Encorafenib5143.9144.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.